Can long‑term oxygen therapy cause changes in voice?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Long-Term Oxygen Therapy Does Not Directly Cause Voice Changes

Long-term oxygen therapy (LTOT) itself does not cause changes in voice. The available clinical practice guidelines on both LTOT and hoarseness do not identify oxygen therapy as a cause of dysphonia.

Evidence from Guidelines

The comprehensive British Thoracic Society guidelines for home oxygen use 1 and BTS emergency oxygen guidelines 2 extensively detail the delivery methods, complications, and side effects of LTOT. None of these guidelines mention voice changes or dysphonia as a complication of oxygen therapy. The documented concerns with LTOT relate to:

  • Humidification issues causing upper airway dryness (not voice changes) 2
  • Fire safety risks
  • Proper oxygen saturation targets
  • Delivery device complications (nasal cannulae dislodgement, skin irritation)

What Actually Causes Voice Changes in This Population

The American Academy of Otolaryngology clinical practice guideline on hoarseness 3, 4 identifies the true culprits for voice changes in patients who may be receiving LTOT:

Inhaled Corticosteroids - The Primary Concern

  • Patients with COPD or asthma requiring LTOT typically use inhaled steroids, which cause dose-dependent mucosal irritation and fungal laryngitis 3
  • A 2025 study demonstrated that long-term inhalational corticosteroid use leads to progressive laryngeal changes including edema (5.3%) and hyperemia (7.1%), with significant voice deterioration over 12 months 5

The Underlying Disease Process

  • COPD itself affects respiratory function and can impact voice quality 4
  • Chronic cough from lung disease causes mechanical trauma to vocal folds

Prior Intubation History

  • Many patients requiring LTOT have had previous hospitalizations with endotracheal intubation
  • 94% of patients intubated >4 days develop laryngeal injury (edema, vocal fold ulceration) 3
  • 44% develop vocal fold granulomas within 4 weeks of extubation 3
  • Chronic phonatory dysfunction can persist long-term after prolonged intubation 3

Clinical Approach

If a patient on LTOT develops voice changes, investigate:

  1. Inhaled medication use - Review all inhalational therapies, particularly corticosteroids
  2. Intubation history - Document any recent or remote intubation events
  3. Underlying disease severity - COPD exacerbations, chronic cough
  4. Tobacco use - Continued smoking increases risk of polypoid lesions and malignancy 3

Do not attribute voice changes to the oxygen therapy itself. The oxygen delivery method (nasal cannulae, masks) does not cause laryngeal pathology, though high-flow systems may cause upper airway dryness that responds to humidification 2.

Important Caveat

Trans-tracheal oxygen delivery (rarely used) 1 involves a surgical procedure that could theoretically affect voice, but this relates to the surgical intervention, not the oxygen therapy itself. Standard nasal cannulae or mask delivery—used in >99% of LTOT patients—has no mechanism to cause voice changes.

References

3
Guideline

clinical practice guideline: hoarseness (dysphonia).

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2009

4
Guideline

clinical practice guideline: hoarseness (dysphonia) (update).

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2018

Related Questions

How should a 10-year-old boy with two episodes of diarrhea, mild abdominal pain, and no fever be managed?
Should a 1.1 cm ovarian follicle be followed up with repeat ultrasound?
How should I manage a 10-month-old infant with a rectal temperature of 100.6 °F and two episodes of vomiting?
What is the recommended evaluation and management for a 10-year-old male with pubic pain, intermittent dysuria for 2–3 months, decreased appetite, and urine specific gravity of 1.015?
Why does an 11‑day‑old neonate who drinks only 45–55 mL of a prescribed 70 mL per feed because of fatigue stop feeding, and what further diagnostic work‑up is indicated?
Does doxylamine cause an elevation in kidney function test results such as serum creatinine or BUN?
How should I interpret an arterial blood gas with pH 7.19, PaCO2 71 mm Hg, PaO2 89 mm Hg, O₂ saturation 98 %, bicarbonate 26.7 mmol/L, base excess –1.5, and hemoglobin 8.5 g/dL?
How should a solitary simple renal cortical cyst be managed in an otherwise healthy adult?
For a neurologically stable patient with mild communicating hydrocephalus, what is the appropriate management and does it constitute an emergency?
What is the differential diagnosis of chronic oral ulcers in an adult lasting eight months and associated with hoarseness of voice?
What is the appropriate evaluation and management for a 51‑year‑old patient with diabetes mellitus who has had diffuse bruising of the trunk, limbs, and back for several months?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.